Kennedy Institute of Ethics Journal 21 (2):141-179 (2011)
AbstractOne of the key ethical requirements for biomedical research is that it have an acceptable risk-benefit profile (Emanuel, Wendler, and Grady 2000). The International Conference of Harmonization guidelines mandate that clinical trials should be initiated and continued only if “the anticipated benefits justify the risks” (1996). Guidelines from the Council for International Organizations of Medical Sciences state that biomedical research is acceptable only if the “potential benefits and risks are reasonably balanced” (2002). U.S. federal regulations require that the “risks to subjects” be “reasonable in relation to anticipated benefits, if any, to subjects and the importance of the knowledge” to be gained from the ..
Similar books and articles
Human Subjects Protections in Biomedical Enhancement Research: Assessing Risk and Benefit and Obtaining Informed Consent.Maxwell J. Mehlman & Jessica W. Berg - 2008 - Journal of Law, Medicine and Ethics 36 (3):546-549.
The Harm-Benefit Tradeoff in "Bad Deal" Trials.Gillian Nycum & Lynette Reid - 2007 - Kennedy Institute of Ethics Journal 17 (4):321-350.
Making Risk-Benefit Assessments of Medical Research Protocols.Alex Rajczi - 2004 - Journal of Law, Medicine and Ethics 32 (2):338-348.
Understanding Risks and Benefits in Research on Reproductive Genetic Technologies.Janet Malek - 2007 - Journal of Medicine and Philosophy 32 (4):339 – 358.
The Ethical Analysis of Risks and Potential Benefits in Human Subjects Research: History, Theory, and Implications for U.S. Regulation.Charles Weijer - unknown
The Re-Emergence of the Liberal-Communitarian Debate in Bioethics: Exercising Self-Determination and Participation in Biomedical Research.E. Christensen - 2012 - Journal of Medicine and Philosophy 37 (3):255-276.
Protecting People in Research: A Comparison Between Biomedical and Traffic Research. [REVIEW]Sara Svensson & Sven Ove Hansson - 2007 - Science and Engineering Ethics 13 (1):99-115.
A System For Identifying Named Entities in Biomedical Text: How Results From Two Evaluations Reﬂect on Both the System and the Evaluations.Christopher Manning - unknown
Lessons From Everyday Lives: A Moral Justification for Acute Care Research.Andrew D. McRae & Charles Weijer - unknown
Ethical Aspects of Vulnerability in Research.Elisabeth Weisser-Lohmann - 2012 - Poiesis and Praxis 9 (1-2):157-162.
Justifying Community Benefit Requirements in International Research.Robert C. Hughes - 2014 - Bioethics 28 (8):397-404.
Added to PP
Historical graph of downloads
Citations of this work
Four Faces of Fair Subject Selection.Katherine Witte Saylor & Douglas MacKay - 2020 - American Journal of Bioethics 20 (2):5-19.
Why Continuing Uncertainties Are No Reason to Postpone Challenge Trials for Coronavirus Vaccines.Robert Steel, Lara Buchak & Nir Eyal - 2020 - Journal of Medical Ethics 46 (12):808-812.
Reconceptualising Risk–Benefit Analyses: The Case of HIV Cure Research.Robert Steel - 2020 - Journal of Medical Ethics 46 (3):212-219.
Clarifying How to Deploy the Public Interest Criterion in Consent Waivers for Health Data and Tissue Research.G. Owen Schaefer, Graeme Laurie, Sumytra Menon, Alastair V. Campbell & Teck Chuan Voo - 2020 - BMC Medical Ethics 21 (1):1-10.
Limits on Risks for Healthy Volunteers in Biomedical Research.David B. Resnik - 2012 - Theoretical Medicine and Bioethics 33 (2):137-149.
References found in this work
Judgment Under Uncertainty: Heuristics and Biases.Amos Tversky & Daniel Kahneman - 1974 - Science 185 (4157):1124-1131.
Limits to Health Care: Fair Procedures, Democratic Deliberation, and the Legitimacy Problem for Insurers.Norman Daniels & James Sabin - 1997 - Philosophy and Public Affairs 26 (4):303-350.
Rethinking the Ethics of Clinical Research: Widening the Lens.Alan Wertheimer - 2010 - Oxford University Press.